» Articles » PMID: 28546856

Epigenetic Regulation of Runx2 Transcription and Osteoblast Differentiation by Nicotinamide Phosphoribosyltransferase

Overview
Journal Cell Biosci
Publisher Biomed Central
Specialty Biology
Date 2017 May 27
PMID 28546856
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone degenerative disorders like osteoporosis may be initiated by age-related shifts in anabolic and catabolic responses that control bone homeostasis. Although there are studies suggesting that metabolic changes occur with stem cell differentiation, the molecular mechanisms governing energy metabolism and epigenetic modification are not understood fully. Here we reported the key role of nicotinamide phosphoribosyltransferase (Nampt), which is the rate-limiting enzyme in the salvage pathway of NAD biosynthesis from nicotinamide, in the osteogenic differentiation of bone marrow stromal cells.

Results: Differentiated bone marrow stromal cells isolated from mice presented with diminished osteogenesis, as evaluated by alkaline phosphatase (ALP) staining, ALP activity and osteoblast-mediated mineralization, compared to cells from mice. Similar results were observed in differentiated Nampt-deficient C3H/10T1/2 and MC3T3-E1 cells. Further studies showed that Nampt promotes osteoblast differentiation through increased function and expression of as tested by luciferase reporter assay, RT-PCR, and Western Blotting. Our data also demonstrated that Nampt regulates transcription in part through epigenetic modification of H3-Lys9 acetylation.

Conclusion: Our study demonstrated that Nampt plays a critical role in osteoblast differentiation through epigenetic augmentation of transcription. NAMPT may be a potential therapeutic target of aging-related osteoporosis.

Citing Articles

Cellular and molecular mechanisms underlying obesity in degenerative spine and joint diseases.

Xiang Q, Wu Z, Zhao Y, Tian S, Lin J, Wang L Bone Res. 2024; 12(1):71.

PMID: 39658574 PMC: 11632072. DOI: 10.1038/s41413-024-00388-8.


Epigenetic Regulation of Autophagy in Bone Metabolism.

Zhang Y, Wang Q, Xue H, Guo Y, Wei S, Li F Function (Oxf). 2024; 5(2):zqae004.

PMID: 38486976 PMC: 10935486. DOI: 10.1093/function/zqae004.


Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol.

Meyer C, Brockmueller A, Buhrmann C, Shakibaei M Nutrients. 2024; 16(5).

PMID: 38474838 PMC: 10934808. DOI: 10.3390/nu16050708.


Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets.

Bilski J, Schramm-Luc A, Szczepanik M, Mazur-Bialy A, Bonior J, Luc K Biomedicines. 2023; 11(11).

PMID: 38001998 PMC: 10669400. DOI: 10.3390/biomedicines11112998.


Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis.

Luo Y, Xiang Y, Lu B, Tan X, Li Y, Mao H J Orthop Surg Res. 2023; 18(1):867.

PMID: 37968755 PMC: 10648345. DOI: 10.1186/s13018-023-04276-5.


References
1.
Papachroni K, Karatzas D, Papavassiliou K, Basdra E, Papavassiliou A . Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med. 2009; 15(5):208-16. DOI: 10.1016/j.molmed.2009.03.001. View

2.
Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney J, Rosen V . The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun. 1990; 172(1):295-9. DOI: 10.1016/s0006-291x(05)80208-6. View

3.
Yanes O, Clark J, Wong D, Patti G, Sanchez-Ruiz A, Benton H . Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol. 2010; 6(6):411-7. PMC: 2873061. DOI: 10.1038/nchembio.364. View

4.
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K . Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89(5):755-64. DOI: 10.1016/s0092-8674(00)80258-5. View

5.
Li Y, He X, Li Y, He J, Anderstam B, Andersson G . Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J Bone Miner Res. 2011; 26(11):2656-64. DOI: 10.1002/jbmr.480. View